home All News open_in_new Full Article

PharmaCorp Files 2024 Year End Audited Financial Statements and MD&A

SASKATOON, Saskatchewan, April 22, 2025 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce the filing on SEDAR+ of its audited financial statements together with associated MD&A for the year ended December 31, 2024. To review the Corporation’s 2024 audited financial statements and associated MD&A please visit SEDAR+ […]


today 5 h. ago attach_file Other

attach_file Other
attach_file Culture
attach_file Economics
attach_file Culture
attach_file Economics
attach_file Economics
attach_file Other
attach_file Other
attach_file Other


ID: 521165434
Add Watch Country

arrow_drop_down